| scholarly article | Q13442814 |
| P50 | author | Jia-Horng Kao | Q56850580 |
| P2093 | author name string | Chun-Jen Liu | |
| Pei-Jer Chen | |||
| Ding-Shinn Chen | |||
| Ming-Yang Lai | |||
| Bing-Fang Chen | |||
| Wen-Ling Huang | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| hepatocellular carcinoma | Q1148337 | ||
| viral load | Q2528140 | ||
| P304 | page(s) | 594-599 | |
| P577 | publication date | 2006-07-18 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study | |
| P478 | volume | 194 |
| Q45373255 | A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan |
| Q40809408 | Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China |
| Q55395370 | Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations. |
| Q35149306 | Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran |
| Q36436879 | Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. |
| Q45375641 | Clinical implications of hepatitis B virus variants. |
| Q42436025 | Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China |
| Q45396707 | Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations |
| Q30487002 | Current hepatitis B treatment guidelines and future research directions |
| Q93136810 | Current perspectives into the evaluation and management of hepatitis B: a review |
| Q39474534 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C. |
| Q46109480 | Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis |
| Q39733406 | Fighting against viral hepatitis: lessons from Taiwan. |
| Q38408847 | Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance |
| Q40445749 | Genotypic profiles of hepatitis B in African immigrants and their clinical relevance. |
| Q36935260 | HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study |
| Q33801305 | HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection |
| Q39428108 | HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV. |
| Q38922362 | Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. |
| Q40051063 | Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance |
| Q57205352 | Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels |
| Q41615602 | Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania |
| Q35692333 | Hepatitis B virus genotypes and genome characteristics in China |
| Q35016383 | Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells |
| Q42122915 | Hepatitis B virus infection and replication in primarily cultured human fetal hepatocytes |
| Q33918324 | Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study |
| Q61443487 | Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review |
| Q27489394 | Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis |
| Q37578500 | Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. |
| Q35950941 | High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study |
| Q40466204 | Higher prevalence of cancer related mutations 1762T/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV/HIV co-infected compared to HBV-mono-infected Chinese adults. |
| Q42222443 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. |
| Q45020360 | Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission |
| Q37081850 | Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma |
| Q43237437 | Inhibition of the replication of hepatitis B virus in vitro by oxymatrine |
| Q26781165 | Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts |
| Q37606546 | New perspectives of biomarkers for the management of chronic hepatitis B. |
| Q45326396 | Nucleos(t)ide Analogue Treatment for Adult Patients with HBeAg-positive Chronic Infection with Genotype C Hepatitis B Virus: A Nationwide Real-life Study |
| Q35711706 | Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma |
| Q33851416 | Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis |
| Q35668724 | Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues |
| Q45354182 | Risk stratification for hepatitis B virus related hepatocellular carcinoma |
| Q34339577 | Risk stratification of HBV infection in Asia-Pacific region. |
| Q42494265 | Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients |
| Q45397838 | Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area |
| Q37280144 | Role of viral factors in the natural course and therapy of chronic hepatitis B. |
| Q40736922 | Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma |
| Q33661054 | Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma |
| Q45401220 | Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan. |
| Q36720027 | Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma |
| Q34514581 | Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma |
| Q37631626 | The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T(1762)A(1764)). |
| Q37936321 | The management of chronic hepatitis B in Asian Americans |
| Q36980704 | The natural history of chronic hepatitis B. |
| Q42492943 | Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma |
| Q38295846 | What can we learn from hepatitis B virus clinical cohorts? |
Search more.